Jump to start of content

ABIM call wait times may be longer than usual Expand/Collapse the ABIM alert.

Due to high volume, ABIM call wait times may be longer than usual. We know how busy you are, so we apologize for any inconvenience this may cause. You can always send us a message at abim.org/contact.

Coronavirus Updates Expand/Collapse the ABIM alert.

At ABIM we are actively monitoring the ongoing spread of coronavirus (COVID-19) and will post regular updates about any changes to scheduled assessments.
Scheduled for an assessment this year? ABIM is working with Pearson VUE to ensure your safety throughout your exam day. Learn more about what to expect at test centers.
Please follow the United States Centers for Disease Control and Prevention (CDC) for the most up-to-date information on the virus.

Breadcrumb trail:

Cardiovascular Board Cardiovascular Disease Exam Committee

Expand All | Collapse All

Mario J. Garcia, MD, Chair

Mario J. Garcia, MD, ChairDr. Garcia is board certified in Internal Medicine, Cardiovascular Disease and Echocardiography. He is Chief of Cardiology at Montefiore Medical Center, and co-Director of the Montefiore Einstein Center for Heart and Vascular Care. He is also Professor of Medicine and Radiology, Albert Einstein College of Medicine.

Dr. Garcia’s previous positions include Director of Cardiac Imaging and Professor of Medicine and Radiology at Mount Sinai Hospital and Medical School; Director of Cardiac Imaging, Cleveland Clinic; and Assistant Professor of Medicine at Dartmouth Hitchcock and the White River Junction VA Medical Center.

He is presently Chair of the American Board of Internal Medicine Cardiovascular Board Cardiovascular Disease Exam Committee, National Board of Echocardiography, Montefiore Accountable Care Organization, American Heart Association – Founder Affiliate, Centro de Diagnóstico y Medicina Avanzada, and Conferencias Médicas y Telemedicina (Santo Domingo, Dominican Republic). He is a past member of the Board of the American Society of Echocardiography, American Society of Nuclear Cardiology, Society of Cardiovascular Computed Tomography and the Intersocietal Accreditation Council.

Dr. Garcia received his medical degree from the Universidad Nacional Pedro Henríquez Ureña, Dominican Republic. He completed training in internal medicine and cardiology at St. Vincent’s Medical Center in Bridgeport, Connecticut; nuclear cardiology at Massachusetts General Hospital; and echocardiography at Cleveland Clinic.

As of May 2020, Dr. Garcia reported the following external relationships:

Work as an author or editor for the following companies, with compensation as listed:

  • Elsevier, receiving royalties for textbook authorship.
  • Wolters Kluwer Health, receiving royalties for textbook authorship.

Dr. Garcia serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:

  • American Heart Association, Chair of CLCVI, without compensation.
  • National Board of Medical Examiners, National Board of Echocardiography Exam Committee, receiving reimbursement for travel expenses.

Dimitri C. Cassimatis, MD

Dimitri C. Cassimatis, MDDr. Cassimatis is Director of the Coronary Care Unit at Emory University Hospital Midtown in Atlanta, Georgia, and divides his clinical time between Emory Midtown and Grady Memorial Hospital. He co-directs the first-year medical student cardiovascular pathophysiology module at Emory's School of Medicine, and is a small group faculty advisor there as well. Dr. Cassimatis is board certified in Internal Medicine, Cardiovascular Disease and Adult Transthoracic Echocardiography.

Before joining Emory as an Assistant Professor in 2010, Dr. Cassimatis spent 11 years as a physician in the United States Army. He served as Chief of the Cardiology Service at the U.S. Army's Landstuhl Regional Medical Center, and prior to this was Chief of the Cardiology Clinic there. He has served on both Ethics and Peer Review Committees on the clinical side, and Admissions and Curriculum Committees on the educational side.

Dr. Cassimatis is a member of the American Board of Internal Medicine Cardiovascular Board Cardiovascular Disease Exam Committee. He serves on the Board of Directors of the Medical Association of Atlanta. He has received numerous awards, including two teaching awards from the Emory Cardiology fellows, two Meritorious Service Medals from the U.S. Army, and the Graves B. Erskine Award for top graduating fellow at Walter Reed in 2005.

Dr. Cassimatis received his bachelor's degree in biochemistry at the University of Chicago and his medical degree from Harvard University, where he was selected to give one of the commencement addresses at his graduation. He completed his internal medicine and cardiology training at Walter Reed Army Medical Center in Washington, DC.

As of April 2019, Dr. Cassimatis reported the following external relationships:

Dr. Cassimatis serves in significant roles with the following organization, receiving reimbursement or compensation as listed:

  • Medical Association of Atlanta, member of Board of Trustees, receiving reimbursement for travel expenses.

Dr. Cassimatis also teaches a cardiology pathophysiology course for Emory University medical students, and also teaches cardiology fellows in clinical practice.

Mina K. Chung, MD

Mina K. Chung, MDDr. Chung is board certified in Internal Medicine, Cardiovascular Disease, and Clinical Cardiac Electrophysiology. She is a staff Clinical Cardiac Electrophysiologist in the Heart and Vascular Institute Department of Cardiovascular Medicine and in the Lerner Research Institute Department of Molecular Cardiology at the Cleveland Clinic. She is a Professor of Medicine in the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University.

Dr. Chung is a member of the American Board of Internal Medicine Cardiovascular Board Cardiovascular Disease Exam Committee. She is also active on committees within the American Heart Association (AHA), American College of Cardiology (ACC) and the Heart Rhythm Society (HRS). She has been Chair of the HRS Scientific and Clinical Documents Committee and is a member of the AHA Electrocardiology and Arrhythmias Committee of the Clinical Cardiology Council, the ACC EP Section Leadership Council, and the Cleveland Clinic Institutional Review Board. She has served on several consensus document and guideline writing committees and the National Institutes of Health (NIH) Clinical Trial Review Committee.

Dr. Chung has authored or co-authored numerous peer-reviewed publications. Her research interests include translational genomics of atrial fibrillation, clinical arrhythmia outcomes and electrophysiology device and ablation outcomes. She is a principal investigator for an NIH-funded grant on functional genomics of atrial fibrillation.

Dr. Chung received a bachelor's degree in chemistry from the University of California, San Diego, and her medical degree from Washington University School of Medicine in St. Louis, Missouri, where she also completed internal medicine residency and chief residency and cardiology and cardiac electrophysiology fellowships.

As of January 2020, Dr. Chung reported the following external relationships:

Work as an author or editor for following companies, with compensation as listed:

  • Elsevier, receiving compensation for authorship.
  • UpToDate, receiving compensation for authorship.

Dr. Chung serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:

  • American College of Cardiology, Member of the Electrophysiology Section Leadership Council, without compensation.
  • American Heart Association, Chair, Arrhythmia and ECG Committee; Member, Committee on Scientific Sessions Program; Member, Atrial Fibrillation Systems of Care Advisory Group; Chair, Scientific Statement on Lifestyle and Risk Factor Modification to Reduce Atrial Fibrillation; Vice Chair, Scientific Statement on Drug-Induced Arrhythmias; Writing Group member, Scientific statement on Subclinical and Device-Detected Atrial Fibrillation; Writing Committee, ISHNE/ISE/HRS Electrocardiology of Channelopathies and Inherited Arrhythmia Disorders, without compensation.
  • French National Research Agency, grant review panel member, to receive honoraria.
  • Heart Rhythm Society, Board of Trustees and liaison to Research Committee, receiving reimbursement for travel expenses.
  • National Institutes of Health, Ad hoc participant NHLBI/NIH Clinical and Integrative Cardiovascular Sciences study section, receiving honoraria.
  • Funding from not-for-profit healthcare-related organizations for clinical trial expenses, salary support and staff, paid to the Cleveland Clinic, from the following organizations:

    • American Heart Association, for an atrial fibrillation strategically-focused research network grant.
    • National Institutes of Health, for a R01 research grant.

    Larry S. Dean, MD

    Larry S. Dean, MDDr. Dean is currently a Professor of Medicine and Surgery at the University of Washington (UW) School of Medicine and Director of the UW Medicine Regional Heart Center in Seattle, Washington. He is board certified in Internal Medicine, Cardiovascular Disease and Interventional Cardiology. Dr. Dean specializes in interventional cardiology and is widely published in that field.

    Previously, Dr. Dean was a Professor of Medicine at the University of Alabama (UAB) School of Medicine where he also served as an Assistant Medical Director of UAB Hospital. While there, he practiced general and interventional cardiology and was involved in the early development of intracoronary stents.

    Dr. Dean is a member of the American Board of Internal Medicine Cardiovascular Board Cardiovascular Disease Committee. He is a fellow of the American College of Cardiology, the American Heart Association and is a Master Interventionalist of the Society for Cardiovascular Angiography and Interventions (SCAI). He is also a past President of SCAI. In addition, he is a member of the American Association for Physician Leadership and the American Medical Informatics Association.

    He received his undergraduate degree and his medical degree from the University of Alabama. Following medical school, Dr. Dean served his internship and residency at the University of Washington School of Medicine and received cardiology training, including interventional cardiology, at the University of Alabama School of Medicine. He also holds a certificate in Medical Management from the University of Washington.

    As of July 2019, Dr. Dean reported the following external relationships:

    Funding for clinical trial expenses and staff, paid to the University of Washington School of Medicine, from the following company:

    • Edwards LifeSciences, for trials evaluating the SAPIEN heart valve (PARTNER I and II trials).

    Dr. Dean serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:

    • American College of Cardiology, serves on the Transcatheter Valve Therapy Registry Stakeholders Committee, receiving honoraria and reimbursement for travel expenses.
    • Society for Cardiovascular Angiography and Interventions, Chair, Budget and Finance Committee, receiving no compensation.

    Paul L. Douglass, MD

    Paul L. Douglass, MDDr. Douglass is a native of Nashville, Tennessee. He joined Metropolitan Atlanta Cardiology Consultants in 1982 and practices Clinical and Interventional Cardiology. Dr. Douglass is Chief, Division of Cardiology and Director, Cardiovascular Services at the Atlanta Medical Center. He is also a past Chairman of the Hospital Board at Atlanta Medical Center. He serves as Clinical Assistant Professor (Cardiology) at Morehouse School of Medicine.

    He has been the recipient of numerous professional awards including the Physician of the Year Award and the Nash – Carter Award from the Atlanta Medical Association; the Distinguished Service Medallion from the Georgia State Medical Association; several years of Teaching Excellence Awards from the Department of Internal Medicine at Atlanta Medical Center; and the Hero Award from the Association of Black Cardiologists. Dr. Douglass has worked diligently on behalf of cardiovascular medicine, serving on the National Heart Lung Blood Institute Advisory Panel and the Special Emphasis Panel and Disparities Working Group. He was instrumental in the planning and establishment of the Georgia chapter of the American College of Cardiology and served as its first Secretary – Treasurer. He also became president and governor of the Georgia chapter of the ACC. Dr. Douglass has participated on numerous committees and task forces for the American College of Cardiology and completed his term as Chair of the Credentials and Membership Committee in 2006. He was also appointed to the Board of Trustees of the ACC. Dr. Douglass is the chair of the Publications Committee for the Journal of the American College of Cardiology. He is past President of the Metro Atlanta American Heart Association; he has served as president of the Atlanta Medical Association, President of the Georgia State Medical Association, and National President of the Association of Black Cardiologists. He currently serves on the Board of Trustees of WellStar Healthcare System.

    He received his undergraduate degree in biology from Northwestern University. His M.D. degree was awarded at Meharry Medical College. He was elected to Alpha Omega Alpha Honor Society in 1976. Dr. Douglass did his postgraduate training in Internal Medicine and Cardiovascular Diseases at Emory University School of Medicine between 1976 and 1982.

    As of March 2020, Dr. Douglass reported the following external relationships:

    Dr. Douglass serves in significant roles with the following organization, receiving reimbursement or compensation as listed:

    • American College of Cardiology Member, Industry Advisory Committee, receiving reimbursement for travel expenses.

    William Lane Duvall, MD

    William Lane Duvall, MDDr. Duvall is the Director of Nuclear Cardiology at Hartford Hospital in Hartford, Connecticut, and Associate Professor of Medicine at the University of Connecticut School of Medicine. He is board certified in Internal Medicine, Cardiovascular Disease, Nuclear Cardiology and Adult Echocardiography.

    Previously, Dr. Duvall worked as a non-invasive cardiologist at Mount Sinai Medical Center for almost 10 years, most recently serving as an Associate Professor of Medicine. During his time there, he worked full-time in the echocardiography and nuclear cardiology laboratories and served in several administrative positions including in the fellowship program and the cardiac care unit.

    Dr. Duvall is a member of the American Board of Internal Medicine Cardiovascular Board Cardiovascular Disease Exam Committee. He is actively involved with the American Society of Nuclear Cardiology, currently serving on the Board of Directors. Additionally, he is a member of the Registry Oversight Committee and the Deputy Chair of the Health Policy Committee.

    Dr. Duvall received a bachelor’s degree in molecular biology from Princeton University and his medical degree from Yale University. He completed his internal medicine internship and residency at Duke University Medical Center, and his cardiovascular disease fellowship at Mount Sinai Medical Center in New York City.

    As of July 2019, Dr. Duvall reported the following external relationships:

    Dr. Duvall serves in significant roles with the following organization, receiving reimbursement or compensation as listed:

    • American Society of Nuclear Cardiology, Board of Directors, Health Care Policy Committee, ImageGuide Registry Committee, receiving honoraria and reimbursement for travel expenses.

    Dr. Duvall also serves as a medical consultant to GE Healthcare Nuclear Cardiology.

    Marie D. Gerhard-Herman, MD

    Dr. Gerhard-Herman is a cardiovascular medicine specialist at Brigham and Women’s Hospital (BWH). In addition, she is an associate professor of medicine at Harvard Medical School. She is board certified in Cardiovascular Disease.

    Dr. Gerhard-Herman’s clinical interests include deep vein thrombosis, general vascular medicine and Hutchinson-Gilford Progeria syndrome. She has authored over 75 peer-reviewed journal articles, as well as numerous educational materials, clinical guidelines and reports. Her research has received support from the National Institutes of Health and Progeria Research Foundation. She is a member of the American Board of Internal Medicine Cardiovascular Board Cardiovascular Disease Exam Committee.

    She received her medical degree from Northeastern Ohio University Medical University. Dr. Gerhard-Herman completed a residency program in internal medicine at Boston City Hospital/Thorndike Memorial Lab (now Boston Medical Center), as well as fellowship programs in cardiovascular disease and vascular medicine at BWH.

    As of April 2019, Dr. Gerhard-Herman reported the following external relationships:

    Dr. Gerhard-Herman serves in significant roles with the following organization, receiving reimbursement or compensation as listed:

    • Progeria Research Foundation, grant funding provided to Brigham and Women's Hospital for vascular ultrasound imaging to assess phenotype and response to therapy in children with Hutchinson-Gilford (HG) progeria syndrome; receiving salary support.

    Garrie J. Haas, MD

    Dr. Haas is Professor of Clinical Medicine at The Ohio State University Wexner Medical Center in Columbus, Ohio. He is the Section Chief of the Advanced Heart Failure and Cardiac Transplant Program at Ohio State, and is the Medical Director of Heart Failure for the Wexner Medical Center. Dr. Haas is board certified in Internal Medicine, Cardiovascular Disease, and Advanced Heart Failure & Transplant Cardiology.

    He was formerly the Director of the Heart Failure Intensive Care Unit at Cleveland Clinic, and directed the heart failure disease management program at Riverside Methodist Hospital in Columbus.

    Dr. Haas is a member of the American Board of Internal Medicine Cardiology Board Cardiovascular Disease Exam Committee. Previously, he held the directorship of the Heart and Vascular Research Organization (HVRO) at Ohio State, which manages over 150 clinical trials for the divisions of cardiology, cardiovascular surgery, and vascular medicine. He is personally actively involved as principle investigator for multiple heart failure clinical trials. Dr. Haas is a member of the heart failure subcommittee of the American College of Cardiology-affiliated Society of Cardiovascular Patient Care. He was previously the Chair of the Heart Failure version 3 writing committee for ACC.

    Dr. Haas received his degree in zoology from Ohio Wesleyan University, and earned his medical degree from Marshall University in Huntington, West Virginia. He completed his medicine residency at The Ohio State University College of Medicine. Dr. Haas also completed fellowships in cardiology, interventional cardiology and heart failure/cardiac transplantation at Ohio State’s College of Medicine.

    As of April 2019, Dr. Haas reported the following external relationships:

    Funding for clinical trial expenses and staff, paid to The Ohio State University, from the following companies:

    • Amgen, for a study of omecamptiv mecarbil on mortality and morbidity in patients with heart failure.
    • Bristol-Myers Squibb, for a clinical trial investigating an intravenous drug for decompensated heart failure.

    Dr. Haas also reported funding for a study involving the influenza vaccine to effectively stop CT events and decompensated heart failure and another study to reducing lung congestion symptoms using the V-Wave shunt in advanced heart failure.

    Barbara Hutchinson, MD, PhD

    Barbara Hutchinson, MD, PhDDr. Hutchinson is the Managing Partner of Chesapeake Cardiac Care, P.A., a cardiology practice located in Annapolis, Maryland. She is board certified in Internal Medicine, Cardiovascular Disease and Sleep Medicine. Dr. Hutchinson is also an instructor in the Department of Internal Medicine at University of Maryland Medical Center in Baltimore, Maryland.

    Previously, Dr. Hutchinson was Medical Director of the Heart and Vascular Unit at Anne Arundel Medical Center and Intensivist at Mercy Medical Center. She was the first African American to hold the title of Chief Resident in Internal Medicine at University of Maryland Hospital. She was also a lecturer in Pharmacology at University of District of Columbia, in the Department of Respiratory Therapy.

    Dr. Hutchinson is a member of the American Board of Internal Medicine Cardiovascular Board Cardiovascular Disease Exam Committee. She is President of the Association of Black Cardiologists, and a Fellow of the American College of Cardiology (FACC). Patients from all over the world seek her out. She is a noted speaker on heart disease in women and how sleep affects heart health. Additionally, Dr. Hutchinson is the recipient of numerous awards for her work.

    Dr. Hutchinson was born in Trinidad and Tobago and she earned her bachelor of science degree in chemistry at the University of the West Indies. She earned her doctoral degree in cardiovascular pharmacology from Howard University in Washington, District of Columbia, and her medical degree and subsequent fellowship in cardiology from the University of Maryland in Baltimore, Maryland.

    As of May 2020, Dr. Hutchinson reported the following external relationships:

    Industry-supported continuing medical education supported by the following, with compensation for travel expenses and honoraria:

    • Novo Nordisk, for a diabetes and heart disease meeting.

    Dr. Hutchinson serves in significant roles with the following organization, receiving reimbursement or compensation as listed:

    • Association of Black Cardiologists, serving as Immediate past President, without compensation.

    Scott Kinlay, MD

    Scott KinlayDr. Scott Kinlay is an interventional cardiologist and vascular medicine and endovascular specialist. He is Associate Chief in Cardiology and Director of the Cardiac Catheterization Laboratory and Vascular Medicine services at the Veterans Affairs Boston Healthcare System. He an Associate Professor in Medicine at Harvard Medical School. He is ABIM Board Certified in Internal Medicine, Cardiology, and Interventional Cardiology. He is board certified by the American Board of Vascular Medicine in General Vascular Medicine and Endovascular Medicine.

    He is a Fellow of the American Heart Association, American College of Cardiology, Society for Vascular Medicine, Society for Cardiovascular Angiography and Interventions, the Royal Australasian College of Physicians, and the Cardiac Society of Australia and New Zealand.

    Dr. Kinlay's research interests include clinical outcomes in patients with coronary and peripheral artery disease, and endothelial function of the peripheral and coronary arteries.

    As of September 2019, Dr. Kinlay reported the following external relationships:

    Dr. Kinlay serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:

    • American Heart Association, Editor of Circulation Cardiovascular Interventions, without compensation.
    • American Board of Vascular Medicine, Board Member, without compensation.
    • American College of Cardiology, Peripheral Vascular Disease Committee Member, without compensation.

    Dr. Kinlay also reported he receives honoraria and reimbursement for travel expenses from Colorado Prevention Center for service on their data safety monitoring board.

    Michael L. Main, MD

    Michael L. Main, MDDr. Michael Main serves as co-Medical Director of Saint Luke's Mid America Heart Institute in Kansas City, and as chair of the Cardiovascular Division within Saint Luke's Physician Group. He is a professor of medicine at the University of Missouri–Kansas City School of Medicine, and is board certified in Cardiovascular Disease by the American Board of Internal Medicine and in Adult Comprehensive Echocardiography by the National Board of Echocardiography.

    Dr. Main earned his medical degree at the University of Iowa College of Medicine. He completed his residency and fellowship at the University of Texas Southwestern Medical Center and an advanced cardiac imaging fellowship at the Cleveland Clinic.

    As of August 2019, Dr. Main reported the following external relationships:

    Dr. Main serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:

    • American Society of Echocardiography, Board of Directors, receiving reimbursement for travel expenses.
    • American College of Cardiology, Board of Governors, without compensation.

    Geoffrey A. Rose, MD

    Geoffrey RoseDr. Rose is Chief, Division of Adult Cardiology for the Sanger Heart & Vascular Institute (SHVI) at Atrium Health, one of the largest not-for-profit health care systems in the US. He formerly served as SHVI’s Medical Director of Cardiac Imaging. His clinical work centers on providing advanced imaging support for SHVI’s Structural Heart and Intraoperative Echocardiography Programs. He is board certified in Cardiovascular Disease (ABIM) and certified in Adult Comprehensive Echocardiography (National Board of Echocardiography). Dr. Rose is Professor of Medicine at Atrium Health and Clinical Professor of Medicine at the University of North Carolina at Chapel Hill School of Medicine.

    Dr. Rose has served as President of the Intersocietal Accreditation Commission (IAC): Echocardiography and as Chair of the IAC Board of Directors. He represents the American Society of Echocardiography (ASE) at the AMA’s Relative Value Scale Update Committee. Dr. Rose was the Program Chair for the ASE 28th Annual Scientific Sessions, and he joined the ASE Board of Directors in 2017.

    Dr. Rose is a member of the American Board of Internal Medicine Cardiovascular Board Cardiovascular Disease Exam Committee. Additionally, he serves as a member of the Board of Advisors for the Carolina Physicians Alliance, a clinically integrated network developed jointly by Atrium Health and physicians based in the Charlotte, North Carolina region.

    Dr. Rose’s educational background and training include a medical degree from the University of Pennsylvania School of Medicine; internship and residency at the Hospital of the University of Pennsylvania (Chief Resident); and fellowship in cardiology at the Massachusetts General Hospital, where he completed a subspecialty fellowship in cardiac ultrasound.

    As of April 2019, Dr. Rose reported the following external relationships:

    Dr. Rose serves in significant roles with the following organization, receiving reimbursement or compensation as listed:

    • American Society of Echocardiography, Board Member, receiving reimbursement for travel expenses.

    Dr. Rose also reports that his institution participates in a “think tank” with other cardiovascular groups, receiving industry support for reimbursement for travel expenses.

    Chittur A. Sivaram, MD

    chittur sivaramDr. Chittur A. (‘C.A.’) Sivaram is a David Ross Professor at University of Oklahoma and serves as the Vice Chief of the Cardiovascular Section for Education and Training (Department of Medicine) and Associate Dean for Continuing Professional Development at the OU College of Medicine.

    He served on the faculty of Texas Tech University at the Amarillo Campus for 9 years, and has been at University of Oklahoma since 1993. He is involved with student, resident and fellow education at OU, and has mentored many trainees and received multiple teaching awards.

    Dr. Sivaram is very active with the American College of Cardiology (ACC) both at the state and national levels, having served as a past Chair of Cardiovascular Fellowship Program Directors group. He was the national Chair for the ABIM’s Competency Based Pilot in IM/Cardiology. He was recognized with the Gifted Educator Award from ACC (2015) and the Laennec Master Clinician Award from AHA (2017). He maintains an active clinical practice at OU Physicians and is sought after locally for his expertise in the field of echocardiography.

    He obtained his medical degree and cardiology training from India, and underwent additional residency and cardiology fellowship training from Canada (Memorial University and University of Alberta).

    As of September 2019, Dr. Sivaram reported the following external relationships:

    Dr. Sivaram serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:

    • American College of Cardiology, Member of Lifelong Learning Oversight Committee, Member of Cardiovascular Management Section Leadership Council, without compensation.
    • American Heart Association, Member of the FIT Workgroup, without compensation.
    • American Society of Echocardiography, Member of Training Committee, without compensation.